Full text
PDFPage 1039
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Begg T. B., Rifkind B. M. Valutazione della terapia con clofibrate nelle arteriopatie periferiche. Minerva Med. 1971 Sep 26;62(72):3469–3475. [PubMed] [Google Scholar]
- Frick M. H., Heinonen O. P., Huttunen J. K., Koskinen P., Mänttäri M., Manninen V. Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population. Ann Med. 1993 Feb;25(1):41–45. doi: 10.3109/07853899309147855. [DOI] [PubMed] [Google Scholar]
- Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newman T. B. Possibly disappointing results of treatment with gemfibrozil. N Engl J Med. 1993 Jan 14;328(2):139–140. doi: 10.1056/NEJM199301143280214. [DOI] [PubMed] [Google Scholar]
- Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]